TrialSignal
Clinical trial intelligence report
P300 Brain Computer Interface Keyboard to Operate Assistive Technology
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT00860951-Jul 28, 2026
NCT ID
NCT00860951
Status
COMPLETED
Phase
Phase 1/2
Sponsor
University of Michigan
Executive brief
Investment-Ready Snapshot
The P300 Brain Computer Interface Keyboard study, sponsored by the University of Michigan, aims to develop a BCI that enables individuals with paralysis to operate technology using brain signals. This innovative approach addresses a significant market need for assistive technologies, particularly for conditions such as Amyotrophic Lateral Sclerosis, spinal cord injuries, and other neuromuscular diseases. The successful development and commercialization of this technology could position the University of Michigan as a leader in the assistive technology market, which is projected to grow significantly due to increasing demand for adaptive devices. Competitive implications include potential partnerships with technology companies specializing in assistive devices and software, as well as the need to navigate existing patents in the BCI space to ensure freedom-to-operate.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00860951
Indication
Healthy
Modality
medical device
Target
Brain Computer Interface (BCI) technology utilizing EEG signals to operate assistive technology.
Intervention
Brain Computer Interface Keyboard
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.